113 related articles for article (PubMed ID: 21605617)
1. An assessment of the impact of physico-chemical and biochemical characteristics on the human kinetic adjustment factor for systemic toxicants.
Valcke M; Krishnan K
Toxicology; 2011 Aug; 286(1-3):36-47. PubMed ID: 21605617
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the impact of the exposure route on the human kinetic adjustment factor.
Valcke M; Krishnan K
Regul Toxicol Pharmacol; 2011 Mar; 59(2):258-69. PubMed ID: 20969910
[TBL] [Abstract][Full Text] [Related]
3. Assessing the impact of child/adult differences in hepatic first-pass effect on the human kinetic adjustment factor for ingested toxicants.
Valcke M; Krishnan K
Regul Toxicol Pharmacol; 2013 Feb; 65(1):126-34. PubMed ID: 23200794
[TBL] [Abstract][Full Text] [Related]
4. Assessing the impact of the duration and intensity of inhalation exposure on the magnitude of the variability of internal dose metrics in children and adults.
Valcke M; Krishnan K
Inhal Toxicol; 2011 Dec; 23(14):863-77. PubMed ID: 22084919
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the human kinetic adjustment factor for the health risk assessment of environmental contaminants.
Valcke M; Krishnan K
J Appl Toxicol; 2014 Mar; 34(3):227-40. PubMed ID: 24038072
[TBL] [Abstract][Full Text] [Related]
6. Estimation of interindividual pharmacokinetic variability factor for inhaled volatile organic chemicals using a probability-bounds approach.
Nong A; Krishnan K
Regul Toxicol Pharmacol; 2007 Jun; 48(1):93-101. PubMed ID: 17367907
[TBL] [Abstract][Full Text] [Related]
7. Modeling interchild differences in pharmacokinetics on the basis of subject-specific data on physiology and hepatic CYP2E1 levels: a case study with toluene.
Nong A; McCarver DG; Hines RN; Krishnan K
Toxicol Appl Pharmacol; 2006 Jul; 214(1):78-87. PubMed ID: 16464483
[TBL] [Abstract][Full Text] [Related]
8. Physiological-model-based derivation of the adult and child pharmacokinetic intraspecies uncertainty factors for volatile organic compounds.
Pelekis M; Gephart LA; Lerman SE
Regul Toxicol Pharmacol; 2001 Feb; 33(1):12-20. PubMed ID: 11259175
[TBL] [Abstract][Full Text] [Related]
9. Assessing human variability in kinetics for exposures to multiple environmental chemicals: a physiologically based pharmacokinetic modeling case study with dichloromethane, benzene, toluene, ethylbenzene, and m-xylene.
Valcke M; Haddad S
J Toxicol Environ Health A; 2015; 78(7):409-31. PubMed ID: 25785556
[TBL] [Abstract][Full Text] [Related]
10. Metabolism, variability and risk assessment.
Dorne JL
Toxicology; 2010 Feb; 268(3):156-64. PubMed ID: 19932147
[TBL] [Abstract][Full Text] [Related]
11. Modeling the Human Kinetic Adjustment Factor for Inhaled Volatile Organic Chemicals: Whole Population Approach versus Distinct Subpopulation Approach.
Valcke M; Nong A; Krishnan K
J Toxicol; 2012; 2012():404329. PubMed ID: 22523487
[TBL] [Abstract][Full Text] [Related]
12. Approaches for evaluating the relevance of multiroute exposures in establishing guideline values for drinking water contaminants.
Krishnan K; Carrier R
J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2008; 26(3):300-16. PubMed ID: 18781539
[TBL] [Abstract][Full Text] [Related]
13. Incorporating pharmacokinetic differences between children and adults in assessing children's risks to environmental toxicants.
Ginsberg G; Hattis D; Sonawane B
Toxicol Appl Pharmacol; 2004 Jul; 198(2):164-83. PubMed ID: 15236952
[TBL] [Abstract][Full Text] [Related]
14. Predicting maternal rat and pup exposures: how different are they?
Yoon M; Barton HA
Toxicol Sci; 2008 Mar; 102(1):15-32. PubMed ID: 18024990
[TBL] [Abstract][Full Text] [Related]
15. Options for incorporating children's inhaled dose into human health risk assessment.
Ginsberg G; Foos B; Dzubow RB; Firestone M
Inhal Toxicol; 2010 Jul; 22(8):627-47. PubMed ID: 20540622
[TBL] [Abstract][Full Text] [Related]
16. Steady-state solutions to PBPK models and their applications to risk assessment I: Route-to-route extrapolation of volatile chemicals.
Chiu WA; White P
Risk Anal; 2006 Jun; 26(3):769-80. PubMed ID: 16834633
[TBL] [Abstract][Full Text] [Related]
17. Evaluating the adequacy of maximum contaminant levels as health-protective cleanup goals: an analysis based on Monte Carlo techniques.
Finley BL; Scott P; Paustenbach DJ
Regul Toxicol Pharmacol; 1993 Dec; 18(3):438-55. PubMed ID: 8128005
[TBL] [Abstract][Full Text] [Related]
18. An assessment of the impact of multi-route co-exposures on human variability in toxicokinetics: A case study with binary and quaternary mixtures of volatile drinking water contaminants.
Tohon H; Valcke M; Haddad S
J Appl Toxicol; 2019 Jul; 39(7):974-991. PubMed ID: 30834571
[TBL] [Abstract][Full Text] [Related]
19. Physiological modeling of age-specific changes in the pharmacokinetics of organic chemicals in children.
Price K; Haddad S; Krishnan K
J Toxicol Environ Health A; 2003 Mar; 66(5):417-33. PubMed ID: 12712630
[TBL] [Abstract][Full Text] [Related]
20. Human variability in xenobiotic metabolism and pathway-related uncertainty factors for chemical risk assessment: a review.
Dorne JL; Walton K; Renwick AG
Food Chem Toxicol; 2005 Feb; 43(2):203-16. PubMed ID: 15621332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
